Canopy Growth Corp (NASDAQ:CGC) — Market Cap & Net Worth

$397.27 Million USD  · Rank #13540

Market Cap & Net Worth: Canopy Growth Corp (CGC)

Canopy Growth Corp (NASDAQ:CGC) has a market capitalization of $397.27 Million ($397.27 Million) as of September 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #13540 globally and #3266 in its home market, demonstrating a -2.12% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Canopy Growth Corp's stock price $0.94 by its total outstanding shares 423037675 (423.04 Million). Also see CGC asset base for a full breakdown of the balance sheet.

Canopy Growth Corp Market Cap History: 2015 to 2026

Canopy Growth Corp's market capitalization history from 2015 to 2026. Data shows change from $9.10 Billion to $397.27 Million (-23.20% CAGR). Also see Canopy Growth Corp cash conversion from operations for how efficiently the company converts equity into cash flow.

Index Memberships

Canopy Growth Corp is a constituent of 2 market indices:

Index Total Market Cap Weight (%) Rank by Market Cap
NASDAQ Health Care
IXHC
$2.67 Trillion 0.01% #366 of 976
NASDAQ Composite
IXIC
$41.95 Trillion 0.00% #1316 of 3165

Weight: Canopy Growth Corp's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Canopy Growth Corp Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Canopy Growth Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Canopy Growth Corp stock price for real-time trading data and today's change.

Latest Price to Sales (P/S) Ratio

1.40x

Canopy Growth Corp's market cap is 1.40 times its annual revenue

Industry average: 0.57x Higher than industry average

Latest Price to Earnings (P/E) Ratio

N/A

P/E ratio not applicable due to negative or zero earnings

What These Ratios Tell Investors:

  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
2017 $100.08 Billion $39.90 Million -$7.52 Million 2508.46x N/A
2018 $113.67 Billion $77.95 Million -$67.28 Million 1458.28x N/A
2019 $89.22 Billion $226.34 Million -$736.28 Million 394.18x N/A
2020 $104.24 Billion $398.77 Million -$1.32 Billion 261.39x N/A
2021 $36.93 Billion $546.65 Million -$1.74 Billion 67.56x N/A
2022 $9.77 Billion $475.70 Million -$310.04 Million 20.54x N/A
2023 $2.16 Billion $333.25 Million -$3.28 Billion 6.49x N/A
2024 $1.16 Billion $297.15 Million -$657.27 Million 3.90x N/A
2025 $482.26 Million $269.00 Million -$598.12 Million 1.79x N/A
2026 $397.27 Million $284.60 Million -$262.91 Million 1.40x N/A

Competitor Companies of CGC by Market Capitalization

Companies near Canopy Growth Corp in the global market cap rankings as of September 18, 2026. Review Canopy Growth Corp tangible equity quality to assess the quality of the company's equity after excluding intangible assets.

Key companies related to Canopy Growth Corp by market ranking:

  • Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #520 globally with a market cap of $52.60 Billion USD.
  • GALDERMA GROUP AG (NYSE:GALDY): Ranked #619 globally with a market cap of $44.48 Billion USD.
  • Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #637 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
  • Haleon plc (NYSE:HLN): Ranked #665 globally with a market cap of $41.22 Billion USD.
Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#520 Takeda Pharmaceutical Co Ltd ADR NYSE:TAK $52.60 Billion $16.65
#619 GALDERMA GROUP AG NYSE:GALDY $44.48 Billion $38.15
#637 Takeda Pharmaceutical Company Limited F:TKDA $43.60 Billion €16.10
#665 Haleon plc NYSE:HLN $41.22 Billion $9.36

Canopy Growth Corp Historical Marketcap From 2015 to 2026

Between 2015 and today, Canopy Growth Corp's market cap moved from $9.10 Billion to $ 397.27 Million, with a yearly change of -23.20%.

Year Market Cap Change (%)
2026 $397.27 Million -17.62%
2025 $482.26 Million -58.39%
2024 $1.16 Billion -46.38%
2023 $2.16 Billion -77.88%
2022 $9.77 Billion -73.54%
2021 $36.93 Billion -64.57%
2020 $104.24 Billion +16.83%
2019 $89.22 Billion -21.51%
2018 $113.67 Billion +13.58%
2017 $100.08 Billion +246.87%
2016 $28.85 Billion +217.06%
2015 $9.10 Billion --

End of Day Market Cap According to Different Sources

On Sep 18th, 2026 the market cap of Canopy Growth Corp was reported to be:

Source Market Cap
Yahoo Finance $397.27 Million USD
MoneyControl $397.27 Million USD
MarketWatch $397.27 Million USD
marketcap.company $397.27 Million USD
Reuters $397.27 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Canopy Growth Corp

NASDAQ:CGC USA Drug Manufacturers - Specialty & Generic
Market Cap
$397.27 Million
Market Cap Rank
#13540 Global
#3266 in USA
Share Price
$0.94
Change (1 day)
+2.57%
52-Week Range
$0.86 - $1.92
All Time High
$568.90
About

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally. The company operates through two segments, Cannabis and Storz & Bickel. It also provides vaporizers and accessories; dried flower and pre-rolled joints, oil, and … Read more